Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Name: Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
Published: 2015
License: Public Domain

ECOG-ACRIN Cancer Research Group · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

gastrointestinal platinum

gastric neuroendocrine carcinoma, intestinal neuroendocrine carcinoma, pancreatic neuroendocrine carcinoma, neuroendocrine carcinoma, etoposide, temozolomide, platinum, capecitabine, gastrointestinal, gastroenteropancreatic, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Related documents